Tag: PCSK9

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to PCSK9

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Added to Collection on: 2024-11-30 09:17:56

Tags for this article:

Lipid metabolism disorders
PCSK9 inhibitors
PCSK9
Familial hypercholesterolemia
ANGPTL3
Low-density lipoprotein
Verve PCSK9-inhibitor gene therapy
Hypercholesterolemia
Cholesterol
Inclisiran
Alnylam Pharmaceuticals
Verve Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
A feline model of human LDLR-related atherosclerosis - bioRxiv

Added to Collection on: 2024-12-07 23:52:32

Tags for this article:

Lipid metabolism disorders
Familial hypercholesterolemia
Low-density lipoprotein receptor gene family
PCSK9
LDL receptor
Hypercholesterolemia
Low-density lipoprotein
Atherosclerosis
Korat
Cholesterol

Click the tags to see associated articles and topics

View Article Details
PCSK9 Inhibitor Market Growth Accelerates to USD 9.3 - GlobeNewswire

Added to Collection on: 2025-02-10 14:21:18

Tags for this article:

PCSK9 inhibitors
Monoclonal antibodies
PCSK9
Lipid metabolism disorders
Alirocumab
Evolocumab
Lipid-lowering agent
Statin
Low-density lipoprotein
Cholesterol
Pharmaceutical industry
AstraZeneca
United States
Wilmington

Click the tags to see associated articles and topics

View Article Details
Atherosclerotic Cardiovascular Disease Market Size to Reach USD 30.6 Billion by 2035 ...

Added to Collection on: 2025-02-17 14:24:50

Tags for this article:

PCSK9 inhibitors
Vascular diseases
Cardiology
Lipoproteins
Inclisiran
Small interfering RNA
PCSK9
Atherosclerosis
Low-density lipoprotein
Statin
Lipid-lowering agent
Cardiovascular disease
IMARC Group

Click the tags to see associated articles and topics

View Article Details
PCSK9 inhibitors: monoclonal antibodies or siRNA? - Medical Republic

Added to Collection on: 2025-03-28 07:37:25

Tags for this article:

PCSK9 inhibitors
Lipid metabolism disorders
Monoclonal antibodies
Statins
PCSK9
Inclisiran
Familial hypercholesterolemia
Alirocumab
Low-density lipoprotein
Evolocumab
Hypercholesterolemia
RNA interference

Click the tags to see associated articles and topics

View Article Details
CMN Weekly (28 March 2025) - Your Weekly CRISPR Medicine News

Added to Collection on: 2025-03-28 13:28:40

Tags for this article:

Gene therapy
Biotechnology
Genetic engineering
Rare diseases
PCSK9
Facioscapulohumeral muscular dystrophy
CRISPR gene editing
Precision BioSciences
Low-density lipoprotein
CAR T cell
Familial hypercholesterolemia
Genome editing
Cas9
CRISPR
EPI
United States
China
Denmark

Click the tags to see associated articles and topics

View Article Details
A statin and PCSK9 alternative is on the horizon—here's what we know so far | MDLinx

Added to Collection on: 2025-03-31 21:24:00

Tags for this article:

CETP inhibitors
Cardiology
Lipid metabolism disorders
Lipoproteins
Quinolines
PCSK9
Low-density lipoprotein
Torcetrapib
Familial hypercholesterolemia
Cholesteryl ester transfer protein
Lipid-lowering agent
Statin
Marschall S. Runge

Click the tags to see associated articles and topics

View Article Details
Lipid Disorder Treatment Market to Witness Stunning Growth with - openPR.com

Added to Collection on: 2025-04-06 17:44:14

Tags for this article:

GABAA receptor positive allosteric modulators
Hypolipidemic agents
Cardiovascular diseases
Familial hypercholesterolemia
Cholesterol
Statin
Lipid-lowering agent
Dyslipidemia
PCSK9
Hyperlipidemia
Cardiovascular disease
Nicotinic Acid

Click the tags to see associated articles and topics

View Article Details
Lipid Disorder Treatment Market to Witness Stunning Growth with Pfizer, AstraZeneca, AbbVie

Added to Collection on: 2025-04-06 18:15:34

Tags for this article:

GABAA receptor positive allosteric modulators
Hypolipidemic agents
Cardiovascular diseases
Familial hypercholesterolemia
Cholesterol
Statin
Lipid-lowering agent
Dyslipidemia
PCSK9
Hyperlipidemia
Cardiovascular disease
Nicotinic Acid

Click the tags to see associated articles and topics

View Article Details
Verve's shares jump by more than 26% on Lilly-partnered gene therapy data

Added to Collection on: 2025-04-14 19:29:03

Tags for this article:

PCSK9 inhibitors
PCSK9
Verve PCSK9-inhibitor gene therapy
Familial hypercholesterolemia
Low-density lipoprotein
Dyslipidemia
Alirocumab
Gene therapy
Evolocumab
Inclisiran
Eli Lilly and Company
Lipoprotein

Click the tags to see associated articles and topics

View Article Details